Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Messing, R. O.
Right arrow Articles by Simon, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Messing, R. O.
Right arrow Articles by Simon, R. P.
NEUROLOGY 1984;34:1582
© 1984 American Academy of Neurology

Drug-induced seizures

A 10-year experience

Robert O. Messing, MD, Richard G. Closson, PharMD and Roger P. Simon, MD

From the Department of Neurology, School of Medicine, and the Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco.

Of 53 patients with drug-induced seizures seen in the last decade, 45% had single seizures, 40% had multiple convulsions, and 15% had status epilepticus. Generalized seizures with focal features were common, but simple partial (motor) seizures occurred in only two patients. Isoniazid, insulin, lidocaine, and psychotropic medications were the most common drugs that caused seizures. Forty-nine patients recovered without ill effects, but 4 patients died of cardiovascular complications. The combined cardiovascular toxicity of the convulsants, antidotes, and anticonvulsants was more important than the number or duration of seizures in determining outcome.

Address correspondence and reprint requests to Dr. Messing, Neurology Service, 4M62, San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110.

Presented in part at the thirty-fifth annual meeting of the American Academy of Neurology, San Diego, CA, April 1983.

Accepted for publication April 3, 1984.




This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
G. P Hubbard and K. R Wolfe
Meperidine Misuse in a Patient with Sphincter of Oddi Dysfunction
Ann. Pharmacother., April 1, 2003; 37(4): 534 - 537.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S.-H. Do, H.-y. Fang, B.-M. Ham, and Z. Zuo
The Effects of Lidocaine on the Activity of Glutamate Transporter EAAT3: The Role of Protein Kinase C and Phosphatidylinositol 3-Kinase
Anesth. Analg., November 1, 2002; 95(5): 1263 - 1268.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
C. H. Tsay, J. C. Partridge, S. F. Villarreal, W. V. Good, and D. M. Ferriero
Neurologic and Ophthalmologic Findings in Children Exposed to Cocaine in Utero
J Child Neurol, January 1, 1996; 11(1): 25 - 30.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
L. D. Kramer, G. E. Locke, A. Ogunyemi, and L. Nelson
Neonatal Cocaine-Related Seizures
J Child Neurol, January 1, 1990; 5(1): 60 - 64.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by AAN Enterprises, Inc.